These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 38530810)
21. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma. Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355 [TBL] [Abstract][Full Text] [Related]
22. ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas. Li J; Zhang Y; Qu Z; Ding R; Yin X Front Cell Infect Microbiol; 2022; 12():956801. PubMed ID: 35959373 [TBL] [Abstract][Full Text] [Related]
23. G-protein Coupled Receptor 34 Promotes Gliomagenesis by Inducing Proliferation and Malignant Phenotype via TGF-Beta/Smad Signaling Pathway. Cheng Y; Heng X; Feng F Technol Cancer Res Treat; 2022; 21():15330338221105733. PubMed ID: 35770303 [No Abstract] [Full Text] [Related]
24. Identification of a novel pyroptosis-related gene signature correlated with the prognosis of diffuse glioma patients. Zhang Y; Xi F; Yu Q; Lou W; Zeng Z; Su N; Gao J; Duan S; Deng Y; Guo S; Lai S; Tang X; Zhang J Ann Transl Med; 2021 Dec; 9(24):1766. PubMed ID: 35071460 [TBL] [Abstract][Full Text] [Related]
25. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma. Zhang W; Li L; Bian PP; Luo QP; Xiong ZT Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030 [TBL] [Abstract][Full Text] [Related]
26. Optimized risk stratification strategy for glioma patients based on the feature genes of poor immune cell infiltration patterns. Wan HT; Su ZJ; Guo ZS; Wen P; Hong XY J Cancer Res Clin Oncol; 2023 Nov; 149(15):13855-13874. PubMed ID: 37535161 [TBL] [Abstract][Full Text] [Related]
27. Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma. Mou Y; Zhang L; Liu Z; Song X BMC Cancer; 2022 Feb; 22(1):215. PubMed ID: 35227235 [TBL] [Abstract][Full Text] [Related]
28. Targeting the LINC00324/miR-16-5p/SEPT2 Signaling Cascade is Effective to Reverse Malignant Phenotypes in Glioblastoma. Chen B; Lin P; Li N Anticancer Agents Med Chem; 2023; 23(13):1535-1544. PubMed ID: 36852794 [TBL] [Abstract][Full Text] [Related]
29. Jiang W; Zheng F; Yao T; Gong F; Zheng W; Yao N Ann Transl Med; 2021 Nov; 9(22):1686. PubMed ID: 34988195 [TBL] [Abstract][Full Text] [Related]
30. CCDC103 as a Prognostic Biomarker Correlated with Tumor Progression and Immune Infiltration in Glioma. Xu Z; Xu H; Chen X; Huang X; Tian J; Zhao J; Liu B; Shi F; Wu J; Pu J Onco Targets Ther; 2023; 16():819-837. PubMed ID: 37873495 [TBL] [Abstract][Full Text] [Related]
31. IGFBP5, as a Prognostic Indicator Promotes Tumor Progression and Correlates with Immune Microenvironment in Glioma. Lin J; Huang G; Zeng Q; Zhang R; Lin Y; Li Y; Huang B; Pan H J Cancer; 2024; 15(1):232-250. PubMed ID: 38164271 [No Abstract] [Full Text] [Related]
32. Exploration of the radiosensitivity-related prognostic risk signature in patients with glioma: evidence from microarray data. Zhang X; Ren Q; Li Z; Xia X; Zhang W; Qin Y; Wu D; Ren C J Transl Med; 2023 Sep; 21(1):618. PubMed ID: 37700319 [TBL] [Abstract][Full Text] [Related]
33. LINC00324 promotes cell proliferation and metastasis of esophageal squamous cell carcinoma through sponging miR-493-5p via MAPK signaling pathway. Sharma U; Kaur Rana M; Singh K; Jain A Biochem Pharmacol; 2023 Jan; 207():115372. PubMed ID: 36493845 [TBL] [Abstract][Full Text] [Related]
34. Identification and validation of a risk signature based on extracellular matrix-related genes in gliomas. Liu J; Li G Medicine (Baltimore); 2021 Apr; 100(16):e25603. PubMed ID: 33879726 [TBL] [Abstract][Full Text] [Related]
35. Expression of overall survival-EMT-immune cell infiltration genes predict the prognosis of glioma. Zheng L; He JJ; Zhao KX; Pan YF; Liu WX Noncoding RNA Res; 2024 Jun; 9(2):407-420. PubMed ID: 38511063 [TBL] [Abstract][Full Text] [Related]
36. Dysregulation of LINC00324 associated with methylation facilitates leukemogenesis in de novo acute myeloid leukemia. Sun GK; Xu ZJ; Nan FY; Tang LJ; Yao DM Int J Lab Hematol; 2022 Jun; 44(3):567-575. PubMed ID: 35218157 [TBL] [Abstract][Full Text] [Related]
37. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma. Zhang Q; Xia T; Qi C; Du J; Ye C BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454 [TBL] [Abstract][Full Text] [Related]
38. LINC00324 affects non-small cell lung cancer cell proliferation and invasion through regulation of the miR-139-5p/IGF1R axis. Zhang M; Lin B; Liu Y; Huang T; Chen M; Lian D; Deng S; Zhuang C Mol Cell Biochem; 2020 Oct; 473(1-2):193-202. PubMed ID: 32734536 [TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 Pattern Provides a New Scoring System and Predicts the Prognosis and Immune Therapeutic Response in Glioma. Jiang F; Lu DF; Zhan Z; Yuan GQ; Liu GJ; Gu JY; Sun XO; Wang Z Cells; 2022 Dec; 11(24):. PubMed ID: 36552760 [TBL] [Abstract][Full Text] [Related]
40. A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma. Wang G; Zhou H; Tian L; Yan T; Han X; Chen P; Li H; Wang W; Xiao Z; Hou L; Xue X Front Oncol; 2021; 11():682932. PubMed ID: 34123852 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]